SCHEMBL467673

SCHEMBL467673

Nc1nc(Nc2ccc(N3CCC(N4CCCC4)CC3)cc2)n(-c2cc3c(nn2)-c2ccccc2OCC3)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 9/20 0.50
FLT3 P36888 5/20 0.48
RET P07949 3/20 0.48
ALK Q9UM73 3/20 0.48
KIT P10721 3/20 0.48
MET P08581 2/20 0.48
SRC P12931 2/20 0.48
KDR P35968 2/20 0.48
EGFR P00533 2/20 0.48
AURKA O14965 1/20 0.48
PDGFRA P16234 1/20 0.48
TYRO3 Q06418 1/20 0.48
DDR1 Q08345 1/20 0.48
MERTK Q12866 1/20 0.48
AURKB Q96GD4 1/20 0.48
HRH3 Q9Y5N1 1/20 0.34
L3MBTL3 Q96JM7 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MBTD1 Q05BQ5 1/20 0.34
JAK3 P52333 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL468644 0.88 AXL (0.61) AXLFLT3RETALKKIT
SCHEMBL1640412 0.88 AXL (0.65) AXLFLT3RETALKKIT
SCHEMBL467715 0.87 AXL (0.51) AXLFLT3RETALKKIT
SCHEMBL468042 0.78 AXL (0.82) AXLFLT3RETALKKIT
SCHEMBL30121740 0.78 AXL (0.82) AXLFLT3RETALKKIT
SCHEMBL467824 0.78 AXL (0.77) AXLFLT3RETALKKIT
SCHEMBL467825 0.78 AXL (0.77) AXLFLT3RETALKKIT
SCHEMBL30121612 0.78 AXL (0.77) AXLFLT3RETALKKIT
SCHEMBL467767 0.77 AXL (0.67) AXLFLT3RETALKKIT
SCHEMBL30090932 0.77 AXL (0.67) AXLFLT3RETALKKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387395-A1 AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER Rigel Pharmaceuticals, Inc. (US) 2011-11-23 EP disclosed
US-8040491-B2 Exposure method, substrate stage, exposure apparatus, and device manufacturing method NIKON CORPORATION (JP) 2011-10-18 US disclosed
WO-2010083465-A1 AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER RIGEL PHARMACEUTICALS, INC. (US) 2010-07-22 WO disclosed